INSIGHTS

In the first critical months a biopharmaceutical product is in-market, stakeholders need accessible, reliable information to make...

We’ve been discussing the importance of an emerging biopharma company’s supply chain team in our recent blog series, “Heroes in...

We’ve been discussing the importance of an emerging biopharma company’s supply chain team in our recent blog series, “Heroes in...

We recently discussed the importance of an emerging biopharma company’s supply chain team, and the reasons we consider them the...

Emerging organizations and the leaders they hire naturally gravitate to what they know when it comes to choosing business...

In their February 2021 article “First-time launchers in the pharmaceutical industry”, McKinsey & Company reported that “many...

Getting a first drug product approved is an exciting, promising milestone in an emerging biopharma company launching its first...

SVA Life Sciences helps biopharmaceutical leaders navigate their successful commercialization journey – a common goal in our line...

Back in 2002, I worked with a client who was a division administrator with the State of Wisconsin. He introduced me to the...

It’s a big deal for an established biotech to launch a new product, but it can be an ordeal for an emerging life science (ELS)...